Nearly 400 submissions were received, including submissions from a wide spectrum of organisations and individuals such as the Centre for Adverse Reaction Monitoring (CARM), the Pharmaceutical Society, District Health Boards, individual pharmacists, community organisations, manufacturers, distributors, retailers, consumers and Medsafe.